PTPRC and breast carcinoma: Similarly, the C1q expression in mesenchymal and immune cells was corroborated by double-staining immunofluorescence analyses of invasive colon and breast cancer specimens using markers specific for epithelial (pan-cytokeratin), mesenchymal (vimentin) or immune cells (CD45) (Supplementary Fig. 1).